Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease.
非糖尿病慢性腎病及腎小球疾病中礦物皮質激素受體拮抗劑的潛在角色。
Clin J Am Soc Nephrol 2024-07-22
Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review.
慢性腎臟病患者合併第二型糖尿病的非類固醇礦物皮質類固醇拮抗劑及高鉀血症監測:敘事性回顧。
Postgrad Med 2024-04-24
Improving Renal Protection in Chronic Kidney Disease Associated with Type 2 Diabetes: The Role of Finerenone.
改善與第二型糖尿病相關的慢性腎病的腎臟保護:Finerenone 的角色。
Endocr Metab Immune Disord Drug Targets 2025-01-10
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease.
使用非類固醇礦物皮質激素受體拮抗劑治療慢性腎病的證據。
Nefrologia (Engl Ed) 2025-03-13
Non-steroidal mineralocorticoid receptor antagonists: a paradigm shift in the management of diabetic nephropathy.
非類固醇礦物皮質激素受體拮抗劑:糖尿病腎病管理的範式轉變。
Kidney Blood Press Res 2025-03-17